References
- ManciaGde BackerGDominiczakA2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens2007251105118717563527
- ManciaGLaurentSAgabiti-RoseiEReappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documentBlood Press20091830834720001654
- JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med20083592417242819052124
- ChrysantSGMelinoMKarkiSLeeJHeyrmanRThe combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety studyClin Ther20083058760418498909
- SokolMCMcGuiganKAVerbruggeRREpsteinRSImpact of medication adherence on hospitalization risk and healthcare costMed Care20054352153015908846
- MathesJKostevKGabrielAPirkOSchmiederRERelation of the first hypertension-associated event with medication, compliance and persistence in naive hypertensive patients after initiating monotherapyInt J Clin Pharmacol Ther20104817318320197011
- BarriosVBrommerPHaagUCalderonAEscobarCOlmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: A randomized, double-blind, parallel-group, multicentre studyClin Drug Investig200929427439
- ChrysantSGOparilSMelinoMKarkiSLeeJHeyrmanREfficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertensionJ Clin Hypertens (Greenwich)20091147548219751459
- MouradJJLe JeuneSEffective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: Post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre studyClin Drug Investig200929419425
- OparilSLeeJKarkiSMelinoMSubgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: Evaluation by baseline hypertension stage and prior antihypertensive medication useJ Cardiovasc Pharmacol20095442743619730391
- VolpeMBrommerPHaagUMieleCEfficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: A randomized, double-blind, parallel-group, multicentre studyClin Drug Investig2009291125
- ChrysantSGLeeJMelinoMKarkiSHeyrmanREfficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertensionJ Hum Hypertens2010218 [Epub ahead of print]
- PuchlerKLaeisPStumpeKOBlood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonistJ Hypertens Suppl200119S41S4811451214
- SchindlerCFerrarioCMOlmesartan for the treatment of arterial hypertensionFuture Cardiol2008435737219804316
- PedrinelliRDell’OmoGMarianiMCalcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertensionJ Hum Hypertens20011545546111464254
- MesserliFHVasodilatory edema: A common side effect of antihypertensive therapyAm J Hypertens20011497897911587169
- WeirMRIncidence of pedal edema formation with dihydropyridine calcium channel blockers: Issues and practical significanceJ Clin Hypertens (Greenwich)2003533033514564133